A randomised trial of idarubicin dose escalation in consolidation therapy following intensive induction chemotherapy incorporating high dose cytarabine in patients with untreated adult acute myeloid leukaemia, to evaluate safety and improve remission rate.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Idarubicin (Primary) ; Cytarabine; Etoposide
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Acronyms ALLG AMLM12
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 23 Jun 2011 New trial record